Entopsis' Convertible Note Round

Entopsis raised a round of funding on March 19, 2015.

Entopsis is a privately held company developing novel biomedical products for research and clinical use, predominantly in the areas of oncology, autoimmune disorders, metabolic disorders and developin…

Articles about Entopsis' Convertible Note Round: